Professor of Surgery (Thoracic Surgery); Chief, Thoracic Surgery; Surgical Director, Thoracic Oncology; Associate Director, Clinical Affairs at Yale Cancer Center
Departments & Organizations
Surgery: Thoracic Surgery | Cancer Center, Yale: Gastrointestinal Cancers Program; Thoracic Oncology Program | Internal Medicine: Pulmonary & Critical Care Medicine: Thoracic Interventional Program | School of Public Health: Cancer Prevention and Control Center | Yale Medical Group
Research Interests
cancer biology, cancer imaging techniques, prognostic markers of cancers, multimodality (multiple therapies for) treatment of cancer, evidence-based medicine
more...
Education
- BS, University of Michigan/ann Arbor, 1976
- M.D., Northwestern University, 1983
Selected Publications
- Anagnostou VK, Bepler G, Syrigos KN, Tanoue LT, Gettinger S, Homer RJ, Boffa D, Detterbeck FC, Rimm DL. High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer. J Clin Oncol 2009;15:4157-64
- Detterbeck FC., Boffa D, Tanoue LT. The New Lung Cancer Staging System. Chest 2009;136:260-71
- Detterbeck FC, Socinski MA, Gralla RJ, Edelman MJ, Jahan TM, Loesch DM, Limentani SA, Govindan R, Ye Z, Monberg M, Obasaju CK. Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC). J Thor Oncol 2008;3:37-45
more...
